OGN

Orogen Royalties Appoints Mr. Chad Wells to the Board of Directors

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—OGN, MMTX, VRE, and ESQ

Organon (OGN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Organon (OGN) Q1 Earnings and Revenues Miss Estimates

Organon Reports Results for the First Quarter Ended March 31, 2026

Organon Cancels First Quarter Earnings Call